Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 HumanigenPharmaxisIterum TherapeuticsIntelGenx TechnologiesTocagen
SymbolOTCMKTS:HGENOTCMKTS:PXSLYNASDAQ:ITRMOTCMKTS:IGXTNASDAQ:TOCA
Price Information
Current Price$1.15$1.16$2.64$0.16$1.03
52 Week RangeN/AN/AHoldBuyHold
Analyst Ratings
Consensus RecommendationN/AN/AHoldBuyHold
Consensus Price TargetN/AN/A$10.33$1.20$7.66
% Upside from Price TargetN/AN/A291.41% upside654.72% upside644.08% upside
Trade Information
Market Cap$137.16 million$30.54 million$37.83 million$15.66 million$23.90 million
Beta-1.280.690.942.070.08
Average Volume24,65248088,756777,1942,259,589
Sales & Book Value
Annual RevenueN/A$39.41 million$40,000.00$740,000.00$40,000.00
Price / SalesN/A0.78921.2923.69615.40
CashflowN/A$0.49 per shareN/AN/AN/A
Price / CashN/A2.39N/AN/AN/A
Book Value($0.13) per share$0.40 per share($1.88) per shareN/A$0.45 per share
Price / BookN/A2.90-1.40∞2.29
Profitability
Net Income$-10,290,000.00$4.97 million$-103,130,000.00$-10,660,000.00$-63,520,000.00
EPSN/AN/A($7.10)($0.11)($2.69)
Trailing P/E Ratio0.000.00N/AN/AN/A
Forward P/E Ratio∞∞N/A∞∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-1,436.66%-176,433.34%
Return on Equity (ROE)N/AN/A-880.10%-263.99%-226.87%
Return on Assets (ROA)-1,199.07%N/A-173.97%-73.24%-91.10%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A7.78%0.37%
Current Ratio0.03%N/A0.32%0.38%1.74%
Quick Ratio0.03%N/A0.32%0.34%1.74%
Ownership Information
Institutional Ownership PercentageN/AN/A50.66%N/A23.66%
Insider Ownership Percentage7.10%N/A51.10%13.91%10.90%
Miscellaneous
Employees3N/A483877
Shares Outstanding114.30 million26.33 million13.96 million110.26 million23.90 million
Next Earnings Date5/1/2020 (Estimated)N/A5/12/2020 (Estimated)5/14/2020 (Estimated)5/5/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel